Skye Bioscience's total assets for Q4 2024 were $72.76M, a decrease of -10.76% from the previous quarter. SKYE total liabilities were $4.61M for the fiscal quarter, a -19.54% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.